Logo image of CPTA

Capitala Finance Crp (CPTA) Stock Fundamental Analysis

NASDAQ:CPTA - Nasdaq -

25.4  +0.85 (+3.46%)

Fundamental Rating

2

CPTA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 225 industry peers in the Capital Markets industry. CPTA may be in some trouble as it scores bad on both profitability and health. CPTA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CPTA has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA 6.05%
ROE 15.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -2.29%
PM (TTM) 79.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

CPTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CPTA has an Altman-Z score of 0.08. This is a bad value and indicates that CPTA is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 1.60 is on the high side and indicates that CPTA has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Altman-Z 0.08
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 14.72 indicates that CPTA has no problem at all paying its short term obligations.
CPTA has a Quick Ratio of 14.72. This indicates that CPTA is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 14.72
Quick Ratio 14.72

More info and screens

2

3. Growth

3.1 Past

CPTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -103.33%.
Measured over the past years, CPTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -57.96% on average per year.
CPTA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.77%.
CPTA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.20% yearly.
EPS 1Y (TTM)-103.33%
EPS 3Y-73.39%
EPS 5Y-57.96%
EPS Q2Q%125.7%
Revenue 1Y (TTM)-36.77%
Revenue growth 3Y-19.71%
Revenue growth 5Y-16.2%
Sales Q2Q%-30.36%

3.2 Future

The Earnings Per Share is expected to grow by 64.41% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -22.03% on average over the next years. This is quite bad
EPS Next Y170.69%
EPS Next 2Y138.5%
EPS Next 3Y94.04%
EPS Next 5Y64.41%
Revenue Next Year-34.4%
Revenue Next 2Y-22.29%
Revenue Next 3Y-22.31%
Revenue Next 5Y-22.03%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPTA Yearly Revenue VS EstimatesCPTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CPTA Yearly EPS VS EstimatesCPTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CPTA. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 34.35, which means the current valuation is very expensive for CPTA.
CPTA is valuated expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 34.35
CPTA Price Earnings VS Forward Price EarningsCPTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -4.73
CPTA Per share dataCPTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

CPTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CPTA's earnings are expected to grow with 94.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y138.5%
EPS Next 3Y94.04%

More info and screens

4

5. Dividend

5.1 Amount

CPTA has a Yearly Dividend Yield of 5.88%, which is a nice return.
CPTA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 5.88%

5.2 History

The dividend of CPTA decreases each year by -32.37%.
CPTA has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-32.37%
Div Incr YearsN/A
Div Non Decr YearsN/A
CPTA Yearly Dividends per shareCPTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2 4 6 8 10

5.3 Sustainability

DPN/A
EPS Next 2Y138.5%
EPS Next 3Y94.04%

More info and screens

Capitala Finance Crp

NASDAQ:CPTA (7/1/2021, 8:00:00 PM)

25.4

+0.85 (+3.46%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.06%
Inst Owner Change0%
Ins Owners17.04%
Ins Owner Change0%
Market Cap68.86M
Analysts60
Price Target15.3 (-39.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.88%
Yearly Dividend1.49
Dividend Growth(5Y)-32.37%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.35
P/S 2.83
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB N/A
EV/EBITDA -4.73
EPS(TTM)-0.11
EYN/A
EPS(NY)0.74
Fwd EY2.91%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.96
BVpS44.74
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.05%
ROE 15.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -2.29%
PM (TTM) 79.62%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.72
Quick Ratio 14.72
Altman-Z 0.08
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.33%
EPS 3Y-73.39%
EPS 5Y-57.96%
EPS Q2Q%125.7%
EPS Next Y170.69%
EPS Next 2Y138.5%
EPS Next 3Y94.04%
EPS Next 5Y64.41%
Revenue 1Y (TTM)-36.77%
Revenue growth 3Y-19.71%
Revenue growth 5Y-16.2%
Sales Q2Q%-30.36%
Revenue Next Year-34.4%
Revenue Next 2Y-22.29%
Revenue Next 3Y-22.31%
Revenue Next 5Y-22.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A